Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,586,623
-
Total 13F shares
-
55,667
-
Share change
-
+55,667
-
Total reported value
-
$725,000
-
Price per share
-
$13.03
-
Number of holders
-
6
-
Value change
-
+$725,000
-
Number of buys
-
6
Institutional Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q3 2018
As of 30 Sep 2018,
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,667 shares.
The largest 6 holders included
GOLDMAN SACHS GROUP INC, MILLENNIUM MANAGEMENT LLC, UBS Group AG, Steward Partners Investment Advisory, LLC, Tower Research Capital LLC (TRC), and WELLS FARGO & COMPANY/MN.
This page lists
6
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.